Caseware UK (AP4) 2024.0.164 2024.0.164 2024-06-292024-06-29false2023-06-30false1Locum services1truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 09094601 2023-06-30 2024-06-29 09094601 2022-06-30 2023-06-29 09094601 2024-06-29 09094601 2023-06-29 09094601 c:Director1 2023-06-30 2024-06-29 09094601 d:PlantMachinery 2023-06-30 2024-06-29 09094601 d:PlantMachinery 2024-06-29 09094601 d:PlantMachinery 2023-06-29 09094601 d:PlantMachinery d:OwnedOrFreeholdAssets 2023-06-30 2024-06-29 09094601 d:MotorVehicles 2023-06-30 2024-06-29 09094601 d:MotorVehicles 2024-06-29 09094601 d:MotorVehicles 2023-06-29 09094601 d:MotorVehicles d:OwnedOrFreeholdAssets 2023-06-30 2024-06-29 09094601 d:FurnitureFittings 2023-06-30 2024-06-29 09094601 d:FurnitureFittings 2024-06-29 09094601 d:FurnitureFittings 2023-06-29 09094601 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-06-30 2024-06-29 09094601 d:ComputerEquipment 2023-06-30 2024-06-29 09094601 d:ComputerEquipment 2024-06-29 09094601 d:ComputerEquipment 2023-06-29 09094601 d:ComputerEquipment d:OwnedOrFreeholdAssets 2023-06-30 2024-06-29 09094601 d:OwnedOrFreeholdAssets 2023-06-30 2024-06-29 09094601 d:CurrentFinancialInstruments 2024-06-29 09094601 d:CurrentFinancialInstruments 2023-06-29 09094601 d:CurrentFinancialInstruments d:WithinOneYear 2024-06-29 09094601 d:CurrentFinancialInstruments d:WithinOneYear 2023-06-29 09094601 d:ShareCapital 2024-06-29 09094601 d:ShareCapital 2023-06-29 09094601 d:RetainedEarningsAccumulatedLosses 2024-06-29 09094601 d:RetainedEarningsAccumulatedLosses 2023-06-29 09094601 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2024-06-29 09094601 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2023-06-29 09094601 c:FRS102 2023-06-30 2024-06-29 09094601 c:AuditExemptWithAccountantsReport 2023-06-30 2024-06-29 09094601 c:FullAccounts 2023-06-30 2024-06-29 09094601 c:PrivateLimitedCompanyLtd 2023-06-30 2024-06-29 09094601 e:PoundSterling 2023-06-30 2024-06-29 iso4217:GBP xbrli:pure

Registered number: 09094601










A J MEDICAL ENTERPRISE LTD








UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 29 JUNE 2024

 
A J MEDICAL ENTERPRISE LTD
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF A J MEDICAL ENTERPRISE LTD
FOR THE YEAR ENDED 29 JUNE 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of A J Medical Enterprise Ltd for the year ended 29 June 2024 which comprise the Balance sheet and the related notes from the Company's accounting records and from information and explanations you have given to us.
 

This report is made solely to the director of A J Medical Enterprise Ltd in accordance with the terms of our agreement. Our work has been undertaken solely to prepare for your approval the financial statements of A J Medical Enterprise Ltd and state those matters that we have agreed to state to him in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than A J Medical Enterprise Ltd and its  director for our work or for this report.
 
 
It is your duty to ensure that A J Medical Enterprise Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the Company's assets, liabilities, financial position and loss. You consider that A J Medical Enterprise Ltd is exempt from the statutory audit requirement for the .
 
 
We have not been instructed to carry out an audit or review of the financial statements of A J Medical Enterprise Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.







Shipleys Tax Planning

20 June 2025
Page 1

 
A J MEDICAL ENTERPRISE LTD
REGISTERED NUMBER: 09094601

BALANCE SHEET
AS AT 29 JUNE 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 5 
13,164
25,960

  
13,164
25,960

Current assets
  

Debtors: amounts falling due within one year
 6 
4,728
77,461

Cash at bank and in hand
 7 
74,773
1,897

  
79,501
79,358

Creditors: amounts falling due within one year
 8 
(5,243)
(4,462)

Net current assets
  
 
 
74,258
 
 
74,896

Total assets less current liabilities
  
87,422
100,856

  

Net assets
  
87,422
100,856


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
87,322
100,756

  
87,422
100,856


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 20 June 2025.






Adnan Jabbar
Page 2

 
A J MEDICAL ENTERPRISE LTD
REGISTERED NUMBER: 09094601

BALANCE SHEET (CONTINUED)
AS AT 29 JUNE 2024

Director

The notes on pages 4 to 7 form part of these financial statements.

Page 3

 
A J MEDICAL ENTERPRISE LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 JUNE 2024

1.


General information

AJ Medical Enterprise Ltd is a company domiciled in England & Wales, registration number 09094601. The registered office is 65 High Street, Heckmondwike, West Yorkshire, WF16 0AD.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.4

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


Page 4

 
A J MEDICAL ENTERPRISE LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 JUNE 2024

2.Accounting policies (continued)

 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery
-
20% straight line
Motor vehicles
-
25% straight line
Fixtures and fittings
-
20% straight line
Computer equipment
-
33% straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.9

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2023 - 1).

Page 5

 
A J MEDICAL ENTERPRISE LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 JUNE 2024

4.


Dividends

2024
2023
£
£


Dividends paid
500
1,000

500
1,000


5.


Tangible fixed assets





Plant and machinery
Motor vehicles
Fixtures and fittings
Computer equipment
Total

£
£
£
£
£



Cost or valuation


At 30 June 2023
2,347
50,690
1,213
9,453
63,703



At 29 June 2024

2,347
50,690
1,213
9,453
63,703



Depreciation


At 30 June 2023
1,732
25,345
1,213
9,453
37,743


Charge for the year on owned assets
123
12,673
-
-
12,796



At 29 June 2024

1,855
38,018
1,213
9,453
50,539



Net book value



At 29 June 2024
492
12,672
-
-
13,164



At 29 June 2023
615
25,345
-
-
25,960

Page 6

 
A J MEDICAL ENTERPRISE LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 JUNE 2024

6.


Debtors

2024
2023
£
£


Other debtors
4,728
77,461

4,728
77,461



7.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
74,773
1,897

74,773
1,897



8.


Creditors: Amounts falling due within one year

2024
2023
£
£

Corporation tax
961
-

Other creditors
3,262
3,442

Accruals and deferred income
1,020
1,020

5,243
4,462



9.


Financial instruments

2024
2023
£
£

Financial assets


Financial assets measured at fair value through profit or loss
74,773
74,773




Financial assets measured at fair value through profit or loss comprise of cash at bank and in hand.


10.


Controlling party

The company is controlled by the director Dr Adnan Jabbar.


Page 7